Hidden gene affects how quickly wounds heal in redheads

Hair color leans heavily on a single gene, the MC1R. This gene governs the balance between eumelanin (brown-black pigment) and pheomelanin (red-yellow pigment) produced in hair follicles.

Most people with brown or black hair carry versions of MC1R that keep the protein active.

Nearly all natural redheads, by contrast, inherit variants that render MC1R partially active or completely switched off, tilting pigment production toward red tones.

Blondes sit somewhere in the middle, with a wider mix of MC1R activity states. The same MC1R protein shows up in the skin, where it helps modulate inflammation.

Because wound repair starts with a short, sharp inflammatory burst and then needs that response to recede, MC1R’s anti-inflammatory role makes it a prime suspect in how efficiently a wound closes.

Healing split seen in mice

Researchers at the University of Edinburgh put this idea to the test using a straightforward model. They created tiny, 4-millimeter circular lesions on the backs of two sets of mice.

One group had black fur and carried a fully functional MC1R. The other had red fur and carried an MC1R that did not work at all.

After seven days, the difference was hard to miss. Lesions on the red-fur mice had shrunk by about 73 percent. The black-fur group had closed roughly 93 percent of the original area.

The outcome aligns with the gene’s biology. Without MC1R’s braking effect, inflammation likely lingers longer than it should. That delay slows the switch into the tissue-rebuilding phase.

Boosting redhead healing speed

The team then flipped the question. If ramping up MC1R activity helps resolve inflammation on time, could a topical drug that boosts the active receptor speed healing in stubborn wounds?

Chronic wounds – especially in diabetes – often stall because persistent inflammation blocks the repair machinery.

The researchers tested an experimental cream designed to enhance signaling through functional MC1R. It would not work on variants that are entirely inactive, but it could supercharge those that still signal.

They created the same small wounds in black-fur mice and treated half with the MC1R-boosting cream under bandages, while the others received saline under identical dressings.

After a week, the treated wounds had shrunk by about 63 percent, more than double the reduction seen in controls over the same period.

Lab analyses pointed to the mechanism the team expected. Fewer inflammatory immune cells were hanging around the lesion, giving the tissue more room and time for repair.

What this means for human skin

Mouse and human skin do not match in every detail, but wound healing stages are broadly conserved, which is why this model is a workhorse for testing therapies.

The Edinburgh group argues the approach should translate to people, including many redheads.

Most redheads carry MC1R variants that still have some signaling capacity, and those partial signals could, in theory, be amplified by a topical agonist.

People with completely inactive MC1R would not benefit from this particular drug design and would need a different strategy.

There’s another reason for optimism: the drug class isn’t entirely new to dermatology. Researchers already use compounds that target MC1R pathways to treat conditions like erythropoietic protoporphyria, where the skin becomes extremely light-sensitive.

That history doesn’t replace a safety trial, but it does suggest the risk profile could be manageable if dosing and delivery are tuned for wounds rather than systemic exposure.

Redhead healing isn’t simple

Experts urge caution on several fronts. First, these findings come from preclinical work, and only controlled human studies can confirm whether the benefit and safety hold up in real-world wounds.

Second, many chronic lesions harbor microbes or biofilms. A cream that dampens inflammation might conceivably blunt protective immune responses in infected wounds, or – just as plausibly – reduce damaging over-inflammation and improve clearance.

That uncertainty has to be resolved in carefully designed trials that stratify patients by infection status.

Researchers at Case Western Reserve University have emphasized this point in broader wound care discussions: the best therapy accelerates closure without compromising antimicrobial defense.

Finally, hair color itself is not destiny. Even among redheads, MC1R activity varies, and overall wound healing outcomes depend on age, circulation, blood sugar control, nutrition, pressure or shear on the tissue, and basic care.

The mouse data suggest a biological tilt, not an inevitability. In everyday life, any delay for a healthy red-haired adult may be modest enough to go unnoticed outside a lab.

The larger inflammation view

What makes this study useful is not just the red hair connection. It’s the broader reminder that timing in inflammation is everything.

The first hours and days after a cut or ulcer are meant to be noisy – immune cells flood in, debris gets cleared. Then the system throttles back, letting fibroblasts rebuild and epithelial cells crawl over fresh tissue. If the brake never engages, healing stalls.

MC1R looks like one of the knobs the body uses to dial that switch, and a topical therapy that turns the knob the right way could be valuable far beyond any single hair color group.

Future research on redhead healing

The Edinburgh team plans to move into human testing, targeting chronic wounds where an anti-inflammatory boost could plausibly shorten the slog to closure.

Success would likely show up as faster wound-area reduction. It would also mean fewer clinic visits for debridement or dressing changes. Infection rates would drop too, because the wounds wouldn’t linger as long.

For now, the takeaway is simple and hopeful: a pigment gene long associated with freckles and sun sensitivity might also be a treatable lever in wound care.

If clinical trials confirm the effect, clinicians could soon have a new, precision tool that helps patients of all hair colors spend less time waiting for skin to heal.

The study is published in the journal Proceedings of the National Academy of Sciences.

—–

Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

—–